ArticleFrontiers in oncology2025

CYP4B1 inhibits lung adenocarcinoma progression via PI3K/AKT/mTOR pathway: mechanistic insights and development of a CYP4B1-related prognostic signature.

Guoyin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.